文献速递眼底病与葡萄膜炎白内障与屈光手术

蓝光滤过型人工晶状体对新生血管性年龄相关性黄斑变性眼黄斑萎缩发生与进展的影响

The Effect of Blue-light Filtering Intraocular Lenses on the Development and Progression of Macular Atrophy in Eyes With Neovascular Age-related Macular Degeneration.
PubMed 文献 · Am J Ophthalmol · 2024-04-29

回顾性临床队列研究纳入373例接受抗VEGF注射且行白内障手术的新生血管性年龄相关性黄斑变性患者,比较蓝光滤过型与非蓝光滤过型人工晶状体对黄斑萎缩的影响;两组新发黄斑萎缩风险无显著差异(HR 1.236,95%CI 0.784-1.949,P=.363),但蓝光滤过型组末次随访黄斑萎缩面积及年均增长更小。

要点

  • 蓝光滤过型与非蓝光滤过型人工晶状体组新发黄斑萎缩风险无显著差异(HR 1.236,95%CI 0.784-1.949,P=.363)。
  • 末次随访黄斑萎缩面积蓝光滤过型组5.14±4.71 mm2,非蓝光滤过型组8.56±9.17 mm2(P=.028)。
  • 年均黄斑萎缩面积增长蓝光滤过型组0.78±0.84 mm2,非蓝光滤过型组1.26±1.32 mm2(P=.042)。

核心结论

  • 蓝光滤过型人工晶状体在无黄斑萎缩生存方面未显示优于非蓝光滤过型人工晶状体,但在新生血管性年龄相关性黄斑变性患者队列中与随时间更少的黄斑萎缩进展相关。

研究设计与样本

  • 回顾性临床队列研究,纳入2007年至2018年间接受无并发症白内障手术且随访至2023年6月的接受抗血管内皮生长因子注射的新生血管性年龄相关性黄斑变性患者。
  • 共纳入373只眼(373例患者),手术时平均年龄78.6±6.7岁,女性占67.4%。
  • 蓝光滤过型人工晶状体植入206只眼,非蓝光滤过型人工晶状体植入167只眼。
  • 所有光学相干断层扫描由经验丰富的研究技师在设盲状态下手动复核,黄斑萎缩面积通过Heidelberg软件手动评估并以mm2计算。
  • 评估新发黄斑萎缩总体风险及人工晶状体类型对疾病进展的影响,死亡作为删失事件。

主要发现

  • 两组随访时间相当(蓝光滤过型组3164±1420天 vs 非蓝光滤过型组3180±1403天,P=.908),其他基线参数(年龄、性别、矫正远视力、黄斑厚度、抗VEGF注射累积次数)亦相当。
  • 检出9例既存黄斑萎缩和77例新发黄斑萎缩,在蓝光滤过型与非蓝光滤过型眼间分布相似(P=.598和P=.399)。
  • 单变量Kaplan-Meier分析(P=.366)及调整年龄和性别的多变量Cox回归分析显示,蓝光滤过型人工晶状体与非蓝光滤过型人工晶状体在新发黄斑萎缩风险方面相当(HR 1.236,95%CI 0.784-1.949,P=.363)。
  • 末次随访黄斑萎缩面积蓝光滤过型组为5.14±4.71 mm2,非蓝光滤过型组为8.56±9.17 mm2(P=.028)。
  • 年均黄斑萎缩面积增长蓝光滤过型组为0.78±0.84 mm2,非蓝光滤过型组为1.26±1.32 mm2(P=.042)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the effect of blue-light filtering (BLF) intraocular lenses (IOLs) on the development and progression of macular atrophy (MA) in eyes with neovascular age-related macular degeneration (nAMD). DESIGN: Retrospective, clinical cohort study. METHODS: The study included patients with nAMD with anti-vascular endothelial growth factor (VEGF) injections who underwent uneventful cataract surgery between 2007 and 2018 with follow-up until June 2023. Subsequent MA rates were compared between subjects who received a BLF IOL or a non-BLF IOL. All optical coherence tomography scans were manually reviewed in a masked manner regarding patient baseline variables and IOL status by an experienced research technician. By using Heidelberg software, the area of MA was manually evaluated and calculated (mm2) by the program. The overall risk of developing new-onset MA and the effect of IOL type on disease progression were assessed. Death was included as a censoring event. RESULTS: Included were 373 eyes of 373 patients (mean age, 78.6 ± 6.7 years at surgery; 67.4% were female). BLF IOLs were implanted in 206 eyes, and non-BLF IOLs were implanted in 167 eyes with comparable follow-up times (3164 ± 1420 days vs 3180 ± 1403 days, respectively, P = .908) and other baseline parameters (age, gender, corrected distance visual acuity, macular thickness, cumulative number of anti-VEGF injections). Nine preexisting and 77 new-onset MA cases were detected, with similar distribution between BLF and non-BLF eyes (P = .598 and P = .399, respectively). Both univariate Kaplan-Meier (P = .366) and multivariate Cox regression analyses adjusted for age and gender showed that BLF-IOLs were comparable to non-BLF IOLs regarding hazard for new-onset MA (hazard ratio [HR], 1.236; 95% CI, 0.784-1.949; P = .363). Final MA area at the last visit was 5.14 ± 4.71 mm2 for BLF IOLs and 8.56 ± 9.17 mm2 for non-BLF IOLs (P = .028), with the mean annual MA area increase of 0.78 ± 0.84 mm2 and 1.26 ± 1.32 mm2, respectively (P = .042). CONCLUSIONS: BLF IOLs did not show added benefit over non-BLF IOLs in terms of MA-free survival but were associated with less progression over time in a cohort of patients with nAMD.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Achiron A, Trivizki O, Knyazer B, et al. The Effect of Blue-light Filtering Intraocular Lenses on the Development and Progression of Macular Atrophy in Eyes With Neovascular Age-related Macular Degeneration. Am J Ophthalmol. 2024. PMID: 38692502. doi:10.1016/j.ajo.2024.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。